Biller Jonathan
Insider CIK 1744749 · AGIO Chief Legal Officer · CELG EVP AND GENERAL COUNSEL · VRTX EVP and Chief Legal Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2026-02-25 | 2026-02-26 | 945 | $486.35 | $459.6K | 13,659 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | F Tax w/h | 2026-02-24 | 2026-02-26 | 1,144 | $485.11 | $555.0K | 14,604 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2026-02-18 | 2026-02-19 | 1,244 | $473.68 | $589.3K | 15,748 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | A Award | 2026-02-17 | 2026-02-19 | 4,135 | — | $0 | 20,973 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | F Tax w/h | 2026-02-17 | 2026-02-19 | 1,505 | $483.75 | $728.0K | 19,468 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2026-02-17 | 2026-02-19 | 2,476 | $489.46 | $1.21M | 16,992 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2026-02-13 | 2026-02-18 | 988 | $499.00 | $493.0K | 16,838 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | F Tax w/h | 2026-02-13 | 2026-02-18 | 2,993 | $487.76 | $1.46M | 17,826 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2026-02-11 | 2026-02-12 | 1,925 | $460.43 | $886.3K | 20,819 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | F Tax w/h | 2026-02-10 | 2026-02-12 | 1,630 | $468.41 | $763.5K | 22,744 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | A Award | 2026-01-22 | 2026-01-26 | 6,294 | — | $0 | 21,600 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | A Award | 2026-01-22 | 2026-01-26 | 2,774 | — | $0 | 24,374 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2025-12-03 | 2025-12-05 | 347 | $449.00 | $155.8K | 15,306 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2025-10-02 | 2025-10-03 | 694 | $404.21 | $280.5K | 15,653 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | F Tax w/h | 2025-10-01 | 2025-10-03 | 1,259 | $400.00 | $503.6K | 16,347 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2025-02-18 | 2025-02-19 | 1,657 | $455.06 | $754.0K | 17,606 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | F Tax w/h | 2025-02-14 | 2025-02-19 | 1,504 | $463.46 | $697.0K | 19,263 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | A Award | 2025-02-12 | 2025-02-14 | 4,437 | — | $0 | 20,767 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2025-02-11 | 2025-02-12 | 3,433 | $459.87 | $1.58M | 16,330 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | F Tax w/h | 2025-02-10 | 2025-02-12 | 1,632 | $467.98 | $763.7K | 19,763 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | A Award | 2025-02-04 | 2025-02-06 | 4,744 | — | $0 | 21,395 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2024-10-02 | 2024-10-03 | 999 | $461.66 | $461.2K | 16,651 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | F Tax w/h | 2024-10-01 | 2024-10-03 | 630 | $466.84 | $294.1K | 17,650 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2024-02-12 | 2024-02-13 | 1,738 | $418.77 | $727.8K | 18,280 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | F Tax w/h | 2024-02-09 | 2024-02-13 | 1,588 | $422.74 | $671.3K | 20,018 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | A Award | 2024-02-07 | 2024-02-08 | 4,743 | — | $0 | 21,606 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | A Award | 2024-02-06 | 2024-02-08 | 6,294 | — | $0 | 16,863 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2023-10-02 | 2023-10-03 | 610 | $346.76 | $211.5K | 10,569 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | F Tax w/h | 2023-09-29 | 2023-10-03 | 408 | $350.72 | $143.1K | 11,179 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | A Award | 2023-02-01 | 2023-02-03 | 6,293 | — | $0 | 11,587 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | A Award | 2022-09-19 | 2022-09-21 | 5,294 | — | $0 | 5,294 | SEC↗ |
| AGIO AGIOS PHARMACEUTICALS, INC | A Award deriv | 2022-03-01 | 2022-03-03 | 11,500 | — | $0 | 11,500 | SEC↗ |
| AGIO AGIOS PHARMACEUTICALS, INC | A Award deriv | 2022-03-01 | 2022-03-03 | 41,000 | — | $0 | 41,000 | SEC↗ |
| AGIO AGIOS PHARMACEUTICALS, INC | F Tax w/h | 2022-02-22 | 2022-02-23 | 2,688 | $29.08 | $78.2K | 22,953 | SEC↗ |
| AGIO AGIOS PHARMACEUTICALS, INC | M Exercise deriv | 2022-02-18 | 2022-02-23 | 8,523 | — | $0 | 8,522 | SEC↗ |
| AGIO AGIOS PHARMACEUTICALS, INC | M Exercise | 2022-02-18 | 2022-02-23 | 8,523 | — | $0 | 25,641 | SEC↗ |
| AGIO AGIOS PHARMACEUTICALS, INC | M Exercise deriv | 2022-02-10 | 2022-02-14 | 3,667 | — | $0 | 7,333 | SEC↗ |
| AGIO AGIOS PHARMACEUTICALS, INC | F Tax w/h | 2022-02-10 | 2022-02-14 | 1,349 | $31.43 | $42.4K | 17,118 | SEC↗ |
| AGIO AGIOS PHARMACEUTICALS, INC | M Exercise | 2022-02-10 | 2022-02-14 | 3,667 | — | $0 | 18,467 | SEC↗ |
| AGIO AGIOS PHARMACEUTICALS, INC | M Exercise deriv | 2021-12-03 | 2021-12-07 | 5,753 | — | $0 | 5,753 | SEC↗ |
| AGIO AGIOS PHARMACEUTICALS, INC | F Tax w/h | 2021-12-03 | 2021-12-07 | 1,823 | $35.88 | $65.4K | 14,800 | SEC↗ |
| AGIO AGIOS PHARMACEUTICALS, INC | M Exercise | 2021-12-03 | 2021-12-07 | 5,753 | — | $0 | 16,623 | SEC↗ |
| AGIO AGIOS PHARMACEUTICALS, INC | A Award deriv | 2021-02-10 | 2021-02-12 | 44,000 | — | $0 | 44,000 | SEC↗ |
| AGIO AGIOS PHARMACEUTICALS, INC | A Award deriv | 2021-02-10 | 2021-02-12 | 11,000 | — | $0 | 11,000 | SEC↗ |
| AGIO AGIOS PHARMACEUTICALS, INC | M Exercise deriv | 2020-12-03 | 2020-12-07 | 5,753 | — | $0 | 11,506 | SEC↗ |
| AGIO AGIOS PHARMACEUTICALS, INC | F Tax w/h | 2020-12-03 | 2020-12-07 | 1,707 | $45.87 | $78.3K | 10,040 | SEC↗ |
| AGIO AGIOS PHARMACEUTICALS, INC | M Exercise | 2020-12-03 | 2020-12-07 | 5,753 | — | $0 | 11,747 | SEC↗ |
| AGIO AGIOS PHARMACEUTICALS, INC | F Tax w/h | 2020-04-14 | 2020-04-15 | 2,529 | $40.64 | $102.8K | 5,994 | SEC↗ |
| AGIO AGIOS PHARMACEUTICALS, INC | M Exercise deriv | 2020-04-13 | 2020-04-15 | 8,523 | — | $0 | 17,045 | SEC↗ |
| AGIO AGIOS PHARMACEUTICALS, INC | M Exercise | 2020-04-13 | 2020-04-15 | 8,523 | — | $0 | 8,523 | SEC↗ |
| AGIO AGIOS PHARMACEUTICALS, INC | A Award deriv | 2019-12-03 | 2019-12-05 | 78,824 | — | $0 | 78,824 | SEC↗ |
| AGIO AGIOS PHARMACEUTICALS, INC | A Award deriv | 2019-12-03 | 2019-12-05 | 17,259 | — | $0 | 17,259 | SEC↗ |
| CELG CELGENE CORP /DE/ | D To issuer deriv | 2019-11-20 | 2019-11-22 | 3,125 | — | $0 | 0 | SEC↗ |
| CELG CELGENE CORP /DE/ | D To issuer deriv | 2019-11-20 | 2019-11-22 | 3,125 | — | $0 | 0 | SEC↗ |
| CELG CELGENE CORP /DE/ | D To issuer deriv | 2019-11-20 | 2019-11-22 | 3,125 | — | $0 | 0 | SEC↗ |
| CELG CELGENE CORP /DE/ | D To issuer deriv | 2019-11-20 | 2019-11-22 | 3,125 | — | $0 | 0 | SEC↗ |
| CELG CELGENE CORP /DE/ | D To issuer deriv | 2019-11-20 | 2019-11-22 | 3,500 | — | $0 | 0 | SEC↗ |
| CELG CELGENE CORP /DE/ | D To issuer deriv | 2019-11-20 | 2019-11-22 | 1,563 | — | $0 | 0 | SEC↗ |
| CELG CELGENE CORP /DE/ | D To issuer deriv | 2019-11-20 | 2019-11-22 | 1,563 | — | $0 | 0 | SEC↗ |
| CELG CELGENE CORP /DE/ | D To issuer deriv | 2019-11-20 | 2019-11-22 | 1,564 | — | $0 | 0 | SEC↗ |
| CELG CELGENE CORP /DE/ | D To issuer deriv | 2019-11-20 | 2019-11-22 | 726 | — | $0 | 0 | SEC↗ |
| CELG CELGENE CORP /DE/ | D To issuer deriv | 2019-11-20 | 2019-11-22 | 1,564 | — | $0 | 0 | SEC↗ |
| CELG CELGENE CORP /DE/ | D To issuer deriv | 2019-11-20 | 2019-11-22 | 19,646 | — | $0 | 0 | SEC↗ |
| CELG CELGENE CORP /DE/ | D To issuer deriv | 2019-11-20 | 2019-11-22 | 4,688 | — | $0 | 0 | SEC↗ |
| CELG CELGENE CORP /DE/ | D To issuer deriv | 2019-11-20 | 2019-11-22 | 3,437 | — | $0 | 0 | SEC↗ |
| CELG CELGENE CORP /DE/ | D To issuer deriv | 2019-11-20 | 2019-11-22 | 3,438 | — | $0 | 0 | SEC↗ |
| CELG CELGENE CORP /DE/ | D To issuer deriv | 2019-11-20 | 2019-11-22 | 3,125 | — | $0 | 0 | SEC↗ |
| CELG CELGENE CORP /DE/ | D To issuer deriv | 2019-11-20 | 2019-11-22 | 3,125 | — | $0 | 0 | SEC↗ |
| CELG CELGENE CORP /DE/ | D To issuer deriv | 2019-11-20 | 2019-11-22 | 6,250 | — | $0 | 0 | SEC↗ |
| CELG CELGENE CORP /DE/ | D To issuer deriv | 2019-11-20 | 2019-11-22 | 6,250 | — | $0 | 0 | SEC↗ |
| CELG CELGENE CORP /DE/ | D To issuer deriv | 2019-11-20 | 2019-11-22 | 3,125 | — | $0 | 0 | SEC↗ |
| CELG CELGENE CORP /DE/ | D To issuer deriv | 2019-11-20 | 2019-11-22 | 2,344 | — | $0 | 0 | SEC↗ |
| CELG CELGENE CORP /DE/ | D To issuer deriv | 2019-11-20 | 2019-11-22 | 2,344 | — | $0 | 0 | SEC↗ |
| CELG CELGENE CORP /DE/ | D To issuer deriv | 2019-11-20 | 2019-11-22 | 781 | — | $0 | 0 | SEC↗ |
| CELG CELGENE CORP /DE/ | D To issuer deriv | 2019-11-20 | 2019-11-22 | 6,288 | — | $0 | 0 | SEC↗ |
| CELG CELGENE CORP /DE/ | D To issuer deriv | 2019-11-20 | 2019-11-22 | 8,000 | — | $0 | 0 | SEC↗ |
| CELG CELGENE CORP /DE/ | D To issuer deriv | 2019-11-20 | 2019-11-22 | 31,714 | — | $0 | 0 | SEC↗ |
| CELG CELGENE CORP /DE/ | D To issuer deriv | 2019-11-20 | 2019-11-22 | 6,719 | — | $0 | 0 | SEC↗ |
| CELG CELGENE CORP /DE/ | D To issuer deriv | 2019-11-20 | 2019-11-22 | 1,563 | — | $0 | 0 | SEC↗ |
| CELG CELGENE CORP /DE/ | D To issuer deriv | 2019-11-20 | 2019-11-22 | 4,687 | — | $0 | 0 | SEC↗ |
| CELG CELGENE CORP /DE/ | A Award | 2019-11-20 | 2019-11-22 | 20,387 | — | $0 | 26,652 | SEC↗ |
| CELG CELGENE CORP /DE/ | D To issuer | 2019-11-20 | 2019-11-22 | 26,652 | — | $0 | 0 | SEC↗ |
| CELG CELGENE CORP /DE/ | D To issuer | 2019-11-20 | 2019-11-22 | 478 | — | $0 | 0 | SEC↗ |
| CELG CELGENE CORP /DE/ | D To issuer | 2019-11-20 | 2019-11-22 | 400 | — | $0 | 0 | SEC↗ |
| CELG CELGENE CORP /DE/ | M Exercise deriv | 2019-10-31 | 2019-11-04 | 3,125 | — | $0 | 0 | SEC↗ |
| CELG CELGENE CORP /DE/ | M Exercise | 2019-10-31 | 2019-11-04 | 3,125 | — | $0 | 7,309 | SEC↗ |
| CELG CELGENE CORP /DE/ | F Tax w/h | 2019-10-31 | 2019-11-04 | 1,044 | $108.03 | $112.8K | 6,265 | SEC↗ |
| CELG CELGENE CORP /DE/ | M Exercise deriv | 2019-05-02 | 2019-05-06 | 1,563 | — | $0 | 0 | SEC↗ |
| CELG CELGENE CORP /DE/ | F Tax w/h | 2019-05-02 | 2019-05-06 | 490 | $95.21 | $46.7K | 4,184 | SEC↗ |
| CELG CELGENE CORP /DE/ | M Exercise | 2019-05-02 | 2019-05-06 | 1,563 | — | $0 | 4,674 | SEC↗ |
| CELG CELGENE CORP /DE/ | A Award deriv | 2019-03-01 | 2019-03-05 | 31,714 | — | $0 | 31,714 | SEC↗ |
| CELG CELGENE CORP /DE/ | M Exercise deriv | 2018-12-16 | 2018-12-18 | 1,900 | — | $0 | 0 | SEC↗ |
| CELG CELGENE CORP /DE/ | F Tax w/h | 2018-12-16 | 2018-12-18 | 935 | $68.20 | $63.8K | 3,111 | SEC↗ |
| CELG CELGENE CORP /DE/ | M Exercise | 2018-12-16 | 2018-12-18 | 1,900 | — | $0 | 4,046 | SEC↗ |
| CELG CELGENE CORP /DE/ | A Award deriv | 2018-07-30 | 2018-08-01 | 4,687 | — | $0 | 4,687 | SEC↗ |